Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Osteoporosis Pipeline Highlights - H2 2016 Update - Research and Markets

Research and Markets
Posted on: 09 Nov 16

Research and Markets has announced the addition of the "Osteoporosis Pipeline Highlights - 2016 Update" drug pipelines to their offering.

Osteoporosis Pipeline Highlights - 2016 Update, provides most up-to-date information on key pipeline products in the global Osteoporosis market. It covers emerging therapies for Osteoporosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Osteoporosis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Osteoporosis pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.


The report provides Osteoporosis pipeline products by the company.

Short-term Launch Highlights:

Find out which Osteoporosis pipeline products will be launched in the US and Ex-US till 2019.

Key Topics Covered:

1. Osteoporosis Pipeline by Stages

2. Osteoporosis Pipeline by Drug Class

3. Osteoporosis Pipeline by Company

4. Osteoporosis Phase 3 Clinical Trial Insights

5. Osteoporosis Phase 2 Clinical Trial Insights

6. Osteoporosis Phase 1 Clinical Trial Insights

7. Osteoporosis Preclinical Research Insights

8. Osteoporosis Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit

View source version on

Business Wire

Last updated on: 09/11/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.